A case of radiation recall pneumonitis induced by erlotinib, which can be related to high plasma concentration

Journal of Thoracic Oncology

Volumn 5, Issue 6, 2010, Pages 924-925

  Togashi, Yosuke ^a   Masago, Katsuhiro ^a   Mishima, Michiaki ^a   Fukudo, Masahide ^a   Inui, Ken Ichi ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CORTICOSTEROID; ERLOTINIB; PACLITAXEL; PROTEIN KINASE INHIBITOR; QUINAZOLINE DERIVATIVE;

AGED; CANCER RADIOTHERAPY; CANCER STAGING; CASE REPORT; DRUG BLOOD LEVEL; DRUG WITHDRAWAL; GENE MUTATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LETTER; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; MALE; MULTIPLE CYCLE TREATMENT; PNEUMONIA; PRIORITY JOURNAL; RADIATION PNEUMONIA; RADIATION RECALL PNEUMONITIS; BLOOD; CARCINOMA, NON-SMALL-CELL LUNG; LUNG NEOPLASMS; RADIATION PNEUMONITIS;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; MALE; PROTEIN KINASE INHIBITORS; QUINAZOLINES; RADIATION PNEUMONITIS;

EID: 77953142120     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3181dab0dd     Document Type: Letter

References (5)

1. Zhang W, Siu LL, Moore MJ, et al. Simultaneous determination of OSI-774 and its major metabolite OSI-420 in human plasma by using HPLC with UV detection. J Chromatogr B Analyt Technol Biomed Life Sci 2005;814:143-147.
2. Yamamoto N, Horiike A, Fujisaka Y, et al. Phase I dose-finding and pharmacokinetic study of the oral epidermal growth factor receptor tyrosine kinase inhibitor Ro50-8231 (erlotinib) in Japanese patients with solid tumors. Cancer Chemother Pharmacol 2008;61:489-496.
3. Cohen MH, Johnson JR, Chen YF, et al. FDA drug approval summary: erlotinib (Tarceva) tablets. Oncologist 2005;10:461-466.
4. Nanda A, Dias-Santagata DC, Stubbs H, et al. Unusual tumor response and toxicity from radiation and concurrent erlotinib for non-small-cell lung cancer. Clin Lung Cancer 2008;9:285-287.
5. Harari PM, Allen GW, Bonner JA. Biology of interactions: antiepidermal growth factor receptor agents. J Clin Oncol 2007;25:4057-4065.